Simulation Modelling in Ophthalmology: Application to Cost Effectiveness of Ranibizumab and Aflibercept for the Treatment of Wet Age-Related Macular Degeneration in the United Kingdom
Crossref DOI link: https://doi.org/10.1007/s40273-016-0459-z
Published Online: 2016-10-27
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Claxton, Lindsay
Hodgson, Robert
Taylor, Matthew
Malcolm, Bill
Pulikottil Jacob, Ruth
License valid from 2016-10-27